Tissue Engineering Part C-Methods

Scope & Guideline

Elevating the Science of Tissue Engineering with Rigorous Research

Introduction

Delve into the academic richness of Tissue Engineering Part C-Methods with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1937-3384
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2008 to 2024
AbbreviationTISSUE ENG PART C-ME / Tissue Eng. Part C-Methods
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

Tissue Engineering Part C-Methods is dedicated to advancing the field of tissue engineering through innovative methodologies, experimental techniques, and practical applications. The journal emphasizes translational research that bridges the gap between laboratory findings and clinical applications. Here are the core areas of focus:
  1. Tissue Engineering Methodologies:
    The journal covers a broad range of methodologies for tissue engineering, including scaffold development, cell culture techniques, and bioreactor systems, focusing on how these techniques can be optimized for better tissue regeneration.
  2. Biomaterials Development:
    Research on various biomaterials, including natural and synthetic polymers, hydrogels, and bioactive glass, is a significant focus. The journal explores how these materials can enhance cell adhesion, proliferation, and differentiation.
  3. Stem Cell Applications:
    The use of stem cells in tissue engineering is a prominent theme, with studies investigating their differentiation pathways and the impact of various scaffolds and growth factors on their regenerative potential.
  4. In Vitro and In Vivo Models:
    The journal emphasizes the development and validation of in vitro and in vivo models for studying tissue engineering applications, critical for assessing the efficacy and safety of engineered tissues.
  5. Immunomodulation in Tissue Engineering:
    Research on how the immune response affects tissue regeneration is increasingly relevant, with studies focusing on techniques to modulate immune responses to improve graft acceptance and functionality.
The journal has seen a rise in interest in several emerging themes that reflect the evolving landscape of tissue engineering and regenerative medicine. These trends indicate areas of significant growth and potential future impact:
  1. 3D Bioprinting Techniques:
    There is a growing trend towards the use of 3D bioprinting technologies for creating complex tissue structures, allowing for precise control over scaffold architecture and cellular organization.
  2. Extracellular Vesicles and Cell Secretome Studies:
    Research focusing on the role of extracellular vesicles and the secretome from various cell types is gaining momentum, highlighting their potential in regenerative therapies and as biomarkers.
  3. Personalized Medicine Approaches:
    The journal is increasingly publishing studies that emphasize personalized medicine, particularly in the context of using patient-derived cells and tailored scaffolds for tissue regeneration.
  4. Integration of AI and Machine Learning:
    The incorporation of artificial intelligence and machine learning techniques into tissue engineering research is on the rise, particularly in optimizing scaffold designs and predicting cell behavior.
  5. Immunomodulatory Biomaterials:
    The development and study of biomaterials that can actively modulate the immune response to enhance tissue integration and regeneration are emerging as a significant area of interest.

Declining or Waning

While Tissue Engineering Part C-Methods continues to thrive in various areas, certain themes have shown a decline in publication frequency. These waning scopes indicate shifts in research focus and methodologies over the years:
  1. Traditional 2D Cell Culture Models:
    There has been a noticeable decline in the publication of studies utilizing traditional 2D cell culture models, as researchers increasingly adopt more advanced 3D culture techniques that better mimic the in vivo environment.
  2. Basic Biomaterial Characterization:
    Research solely focused on the basic characterization of biomaterials without application to specific tissue engineering challenges is becoming less common, as the field moves towards more applied research that addresses clinical needs.
  3. Animal Models with Limited Clinical Relevance:
    Studies involving animal models that do not translate well into human applications are decreasing, with a shift towards models that better represent human physiology and disease states.
  4. Non-Functionalized Biomaterials:
    The exploration of non-functionalized biomaterials is diminishing as the focus shifts towards biofunctionalization strategies that enhance interaction with biological systems and improve regenerative outcomes.

Similar Journals

Regenerative Engineering and Translational Medicine

Innovating Biomaterials for Tomorrow's Therapies
Publisher: SPRINGER HEIDELBERGISSN: 2364-4133Frequency: 4 issues/year

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

Tissue Engineering Part B-Reviews

Exploring Innovative Solutions in Regenerative Medicine.
Publisher: MARY ANN LIEBERT, INCISSN: 1937-3368Frequency: 6 issues/year

Tissue Engineering Part B-Reviews is a premier academic journal published by MARY ANN LIEBERT, INC, focusing on the interdisciplinary field of tissue engineering and regenerative medicine. With an impressive impact factor that places it in the Q1 category across multiple relevant fields—including Biochemistry, Bioengineering, Biomaterials, and Biomedical Engineering—this journal provides a vital platform for researchers and professionals to disseminate cutting-edge findings and comprehensive reviews. Covering a vast scope from 2008 to 2024, the journal is committed to advancing knowledge in the application of engineering principles to biological tissues, making it an indispensable resource for those at the forefront of biomedical innovation. While the journal does not currently offer open access options, its rigorous peer review process ensures high-quality contributions that are essential for academic and practical advancements. The journal's rankings in Scopus reflect its significance, catering to a diverse audience of students, researchers, and practitioners seeking the latest insights in this dynamic field.

Stem Cells International

Connecting Researchers to Transform Stem Cell Science
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE

Transforming Healthcare with Cutting-edge Materials Research
Publisher: SPRINGERISSN: 0957-4530Frequency: 1 issue/year

JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE is a leading peer-reviewed journal published by Springer, dedicated to advancing the field of biomedical materials science. With an ISSN of 0957-4530 and E-ISSN 1573-4838, this Open Access journal has been committed to providing researchers and professionals with freely accessible, high-quality research since 2021. It features an extensive scope spanning bioengineering, biomaterials, biomedical engineering, and biophysics, reflecting its significant impact within these interdisciplinary domains. Recognized within the Q2 category of the 2023 rankings in multiple fields, the journal proudly positions itself as a crucial resource for innovative materials that contribute to advancements in medical applications. With impressive Scopus rankings, including 26th in Biophysics and 40th in Materials Science for Biomaterials, researchers, students, and industry professionals alike can rely on this publication for cutting-edge insights that drive the future of medical materials and technologies. Based in Dordrecht, Netherlands, the journal provides a vibrant platform for sharing groundbreaking discoveries and fostering collaborative research among a global audience.

Tissue Engineering and Regenerative Medicine

Connecting Research and Practice in Biomedical Innovation
Publisher: KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOCISSN: 1738-2696Frequency: 6 issues/year

Tissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.

CELLS TISSUES ORGANS

Advancing the Frontiers of Cellular Science.
Publisher: KARGERISSN: 1422-6405Frequency: 6 issues/year

CELLS TISSUES ORGANS is a renowned academic journal published by KARGER, focusing on pivotal research within the fields of Anatomy and Histology. Based in Switzerland, this journal has been disseminating influential scientific findings since 1889, contributing to our understanding of cellular structures and tissue functionality. With a current impact factor that places it in the Q2 quartile for both disciplines, it serves as a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions in these areas. The journal embraces an Open Access model, ensuring that high-quality, peer-reviewed articles are freely available, thus enhancing visibility and accessibility of critical research. As it continues to foster scholarly communication and innovation up to 2024, CELLS TISSUES ORGANS plays a crucial role in shaping the future of biological sciences and medical research.

JOURNAL OF BIOMATERIALS APPLICATIONS

Elevating research in biomaterials for healthcare advancement.
Publisher: SAGE PUBLICATIONS LTDISSN: 0885-3282Frequency: 8 issues/year

JOURNAL OF BIOMATERIALS APPLICATIONS, published by SAGE PUBLICATIONS LTD, serves as a pivotal platform for the dissemination of cutting-edge research in the field of biomaterials and biomedical engineering. With an ISSN of 0885-3282 and an E-ISSN of 1530-8022, this journal has been a respected venue for scholarly communication since its inception in 1986. Aiming to provide comprehensive insights into the applications of biomaterials, this journal publishes high-quality articles that explore innovative materials and methodologies, thereby fostering advancements in medical technology and tissue engineering. The journal consistently ranks in the third quartile (Q3) for both Biomaterials and Biomedical Engineering categories, strengthening its position among the noteworthy academic resources available today. With a dedicated readership comprising researchers, industry professionals, and students, JOURNAL OF BIOMATERIALS APPLICATIONS plays a vital role in supporting knowledge exchange and scientific progress within these dynamic fields.

Journal of Biological Engineering

Connecting Scholars to Drive Biological Innovation
Publisher: BMCISSN: 1754-1611Frequency: 1 issue/year

Journal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.

Nature Biomedical Engineering

Fostering Collaboration for a Healthier Tomorrow
Publisher: NATURE PORTFOLIOISSN: 2157-846XFrequency: 12 issues/year

Nature Biomedical Engineering is a premier journal published by NATURE PORTFOLIO, focusing on innovative research at the intersection of engineering and biomedical sciences. With an ISSN of 2157-846X, this journal aims to disseminate groundbreaking studies that advance the field of bioengineering, biotechnology, and medical applications. Since its inception in 2017, it has rapidly earned a reputation for excellence, consistently achieving a Q1 ranking in various categories including Bioengineering and Biomedical Engineering, and receiving acclaim in prestigious Scopus rankings, boasting top positions in the fields of Computer Science Applications and Medicine. The journal operates under a rigorous peer-review process, ensuring that all published articles contribute substantially to the existing body of knowledge. Furthermore, it facilitates a broad accessibility model for researchers and practitioners, bolstering collaboration and innovation within the global scientific community. Nature Biomedical Engineering is not just a publication; it serves as a vital platform for thought leadership in the transformative field of biomedical engineering.

Materials Today Bio

Showcasing groundbreaking discoveries in bioengineering and biomaterials.
Publisher: ELSEVIERISSN: 2590-0064Frequency: 4 issues/year

Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.